Akero Therapeutics Inc. (AKRO)
NASDAQ: AKRO
· Real-Time Price · USD
48.69
-0.69 (-1.40%)
At close: Aug 18, 2025, 3:59 PM
50.99
4.72%
After-hours: Aug 18, 2025, 06:11 PM EDT
-1.40% (1D)
| Bid | 47 |
| Market Cap | 3.89B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -269.44M |
| EPS (ttm) | -3.81 |
| PE Ratio (ttm) | -12.78 |
| Forward PE | -11.46 |
| Analyst | Strong Buy |
| Ask | 55 |
| Volume | 413,854 |
| Avg. Volume (20D) | 1,544,991 |
| Open | 49.16 |
| Previous Close | 49.38 |
| Day's Range | 48.46 - 49.58 |
| 52-Week Range | 21.34 - 58.40 |
| Beta | -0.28 |
About AKRO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AKRO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AKRO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
+97.52%
Akero Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
